Welcome to USC Stem Cell, a university wide initiative connecting researchers and highlighting the latest news in regenerative medicine across USC.
December 4, 2013
By Robert Perkins
Robert Maxson Jr., an executive committee member of USC Stem Cell, is one of six USC scientists to be elected fellow of the American Association for the Advancement of Science (AAAS).
November 26, 2013
By Ellin Kavanagh and Cristy Lytal
With the launch of the Translational Biomedical Imaging Lab (TBIL), investigators at the University of Southern California (USC) and The Saban Research Institute of Children’s Hospital Los Angeles moved us closer to a day when diseases can be detected before symptoms appear.
November 20, 2013
In 1993, the Human Frontier Science Program (HFSP) funded three researchers through one of the program’s prestigious Research Grants to work jointly on patterning of the mid-hindbrain region of the vertebrate embryo. Their transatlantic project is a textbook example of a collaboration between three investigators who followed their instincts in curiosity driven research and two decades later are able to present a major breakthrough in the treatment of skin cancer.
Andy McMahon, then at Harvard University and now at the University of Southern California, Clifford Tabin, Harvard Medical School, and Philip Ingham, then at the Imperial Cancer Research Fund in Oxford and now at A*STAR Singapore, joined efforts to investigate fundamental mechanisms that regulate the development of the early mid-hindbrain region in zebra fish, chick and mouse. (more…)
November 14, 2013
University Professor Mark Humayun, internationally known for his work on the Argus II artificial retina implant intended to restore sight to the blind, has been named the inaugural director of the USC Eye Institute and interim chair of the USC Department of Ophthalmology. He is also an affiliate principal investigator with USC Stem Cell.
In his new role, Humayun takes the reins of a local and national leader in eye care services, providing advanced surgical techniques and comprehensive care for patients. Humayun will also continue to lead and guide transformative research.